{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:16:09Z","timestamp":1780359369661,"version":"3.54.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Deep fungal infection is a type of life-threatening opportunistic infection. Its incidence has been increasing in recent years. This infection can affect the prognosis of patients, prolong hospital stays and raise costs for patients and their families.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We aimed to understand the current situation of deep fungal infections in the First Affiliated Hospital of Kunming Medical University and to provide a basis for the clinical diagnosis and treatment of deep fungal infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective analysis of 528,743 cases in the hospital from 2015 to 2019, including the epidemiological characteristics, treatment and prognosis of deep fungal infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 274 cases (0.05%) with deep fungal infections were identified, accounting for 0.05% of the total number of hospitalizations. The incidence of deep fungal infections in the hospital showed an increasing trend from 2015 to 2019. The most commonly infected site was the respiratory tract (93.07%). Among patients with deep fungal infections, 266 specimens were positive for fungal culture, by which 161 cultured <jats:italic>Candida albicans<\/jats:italic> (<jats:italic>C. albicans<\/jats:italic>), accounting for 60.53%, the main pathogen causing deep fungal infection. From 2015 to 2019, the percentage of <jats:italic>C. albicans<\/jats:italic> cases showed a downward trend, while that of non-<jats:italic>C. albicans<\/jats:italic> showed an opposite trend. Antibiotics were the most common predisposing factor for deep fungal infections (97.45%). Among the underlying diseases of patients with deep fungal infections, infectious diseases (59.49%) were the most common. Those with underlying diseases such as renal insufficiency and neurological diseases had a worse prognosis. Indwelling catheters, nervous system disease and tumors were risk factors for a poor prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We report for the first time the epidemiological data of deep fungal infections in a general hospital in southwestern China from 2015 to 2019. In the past 5 years, the number of patients with deep fungal infections in the First Affiliated Hospital of Kunming Medical University has been increasing. Although the clinical data are limited, these results can provide references for the diagnosis and treatment of deep fungal infections.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.842434","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T23:47:55Z","timestamp":1648597675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Deep Fungal Infections Among General Hospital Inpatients in Southwestern China: A 5-Year Retrospective Study"],"prefix":"10.3389","volume":"10","author":[{"given":"Shu-Ran","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Xiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Kui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qun","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2334-13-10","article-title":"A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study","volume":"13","author":"Yang","year":"2013","journal-title":"BMC Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.4103\/0972-5229.195723","article-title":"Risk factors for early invasive fungal disease in critically ill patients","volume":"20","author":"Sai Saran","year":"2016","journal-title":"Indian J Crit Care Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","article-title":"Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer","volume":"17","author":"Colombo","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"104616","DOI":"10.1016\/j.micpath.2020.104616","article-title":"Distribution of invasive fungal infections: Molecular epidemiology, etiology, clinical conditions, diagnosis and risk factors: a 3-year experience with 490 patients under intensive care","volume":"152","author":"Borjian Boroujeni","year":"2021","journal-title":"Microb Pathog."},{"key":"B6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jcla.21580","article-title":"Incidence of pulmonary aspergillosis and correlation of conventional diagnostic methods with nested PCR and real-time PCR assay using BAL fluid in intensive care unit patients","volume":"27","author":"Zarrinfar","year":"2013","journal-title":"J Clin Lab Anal."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e04889","DOI":"10.1002\/ccr3.4889","article-title":"First report of invasive Aspergillus rhinosinusitis in a critically ill COVID-19 patient affected by acute myeloid leukemia, northeastern Iran","volume":"9","author":"Hosseinikargar","year":"2021","journal-title":"Clin Case Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect."},{"key":"B9","first-page":"661","article-title":"Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013","volume":"18","author":"Montagna","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1213\/ane.0b013e3181607262","article-title":"Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome","volume":"106","author":"Dimopoulos","year":"2008","journal-title":"Anesth Analg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/jof7050330","article-title":"Emerging Invasive Fungal Infections in Critically Ill Patients: Incidence, Outcomes and Prognosis Factors, a Case-Control Study","volume":"7","author":"Larcher","year":"2021","journal-title":"J Fungi (Basel)."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3760\/cma.j.cn112138-20200627-00624","article-title":"The Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (the 6th revision)","volume":"59","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/ajd.13262","article-title":"Disseminated phaeohyphomycosis caused by Cyphellophora ludoviensis: A novel case report from Iran","volume":"61","author":"Layegh","year":"2020","journal-title":"Australas J Dermatol."},{"key":"B15","first-page":"331","article-title":"Molecular Identification of Candida Species in Bronchoalveolar Lavage Specimens of Hospitalized Children with Pulmonary Disorders","volume":"23","author":"Kashefi","year":"2021","journal-title":"JBUMS"},{"key":"B16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/ciab336","article-title":"Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999-2018","volume":"74","author":"Rayens","year":"2022","journal-title":"Clin Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bjm.2015.02.001","article-title":"Rapid detection of Candida species in bronchoalveolar lavage fluid from patients with pulmonary symptoms","volume":"47","author":"Zarrinfar","year":"2016","journal-title":"Braz J Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1440-1843.2012.02150.x","article-title":"Pulmonary fungal infections","volume":"17","author":"Smith","year":"2012","journal-title":"Respirology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"553648","DOI":"10.3389\/fcimb.2020.553648","article-title":"A 5-Year Review of Invasive Fungal Infection at an Academic Medical Center","volume":"10","author":"Li","year":"2020","journal-title":"Front Cell Infect Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"625024","DOI":"10.3389\/fbioe.2020.625024","article-title":"Strain Distribution and Drug Susceptibility of Invasive Fungal Infection in Clinical Patients With Systemic Internal Diseases","volume":"8","author":"Zeng","year":"2021","journal-title":"Front Bioeng Biotechnol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.idc.2017.05.005","article-title":"Invasive Fungal Infections in the Intensive Care Unit","volume":"31","author":"Ostrosky-Zeichner","year":"2017","journal-title":"Infect Dis Clin North Am."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","article-title":"French Mycosis Study Group. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)","volume":"40","author":"Lortholary","year":"2014","journal-title":"Intensive Care Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/tid.12613","article-title":"TRANSNET Investigators. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"18","author":"Andes","year":"2016","journal-title":"Transpl Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/jac\/dkv445","article-title":"Drug resistance mechanisms and their regulation in non-albicans Candida species","volume":"71","author":"Ko\u0142aczkowska","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/jac\/dks482","article-title":"Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study","volume":"68","author":"Eschenauer","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11739-021-02705-z","article-title":"Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study","volume":"16","author":"Corcione","year":"2021","journal-title":"Intern Emerg Med."},{"key":"B29","article-title":"Retrospctive Analysis of Deep Fungus Infection of Inpatients in General Hospital","author":"Cheng","year":"2015","journal-title":"J Kunming Med Univ."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e23738","DOI":"10.1002\/jcla.23738","article-title":"Association of different Candida species with catheter-related candidemia, and the potential antifungal treatments against their adhesion properties and biofilm-forming capabilities","volume":"35","author":"Zuo","year":"2021","journal-title":"J Clin Lab Anal."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1128\/AAC.01701-10","article-title":"Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion","volume":"55","author":"Uppuluri","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ajoms.2019.01.007","article-title":"Fungal biofilms in sinonasal polyposis: The role of fungal agents is notable?","volume":"31","author":"Nourizadeh","year":"2019","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4314\/ejhs.v28i6.2","article-title":"Tuberculosis Status and Coinfection of Pulmonary Fungal Infections in Patients Referred to Reference Laboratory of Health Centers Ghaemshahr City during 2007-2017","volume":"28","author":"Amiri","year":"2018","journal-title":"Ethiop J Health Sci"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.842434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T23:47:59Z","timestamp":1648597679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.842434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":33,"alternative-id":["10.3389\/fpubh.2022.842434"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.842434","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"article-number":"842434"}}